{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:35:22Z","timestamp":1782844522748,"version":"3.54.5"},"reference-count":42,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.1167\/tvst.14.12.19","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:31:03Z","timestamp":1765816263000},"page":"19","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical Study on the Long-Term Efficacy and Safety of Sustained-Release Gas6 Liposomes Combined With MERTK Gene Therapy for Retinitis Pigmentosa"],"prefix":"10.1167","volume":"14","author":[{"given":"Shen","family":"Wu","sequence":"first","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyan","family":"Mao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Yan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Teng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Key Laboratory of Intelligent Diagnosis Technology and Equipment for Optic Nerve-Related Eye Diseases, Capital Medical University, Beijing, People's Republic of China"},{"name":"Henan Academy of Innovations in Medical Science, Zhengzhou, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives","volume":"63","author":"Dias","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/issn.0250-3751","article-title":"Retinitis pigmentosa and other dystrophies","volume":"47","author":"Sahel","year":"2010","journal-title":"Dev Ophthalmol"},{"issue":"7","key":"bib3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/bjo.2008.147397","article-title":"Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene","volume":"93","author":"Charbel Issa","year":"2009","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"bib4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1101\/gr.144105.112","article-title":"Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes","volume":"23","author":"Abu-Safieh","year":"2013","journal-title":"Genome Res"},{"issue":"6","key":"bib5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/gim.2015.127","article-title":"Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies","volume":"18","author":"Patel","year":"2016","journal-title":"Genet Med"},{"issue":"3","key":"bib6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/mt.2012.280","article-title":"A comprehensive review of retinal gene therapy","volume":"21","author":"Boye","year":"2013","journal-title":"Mol Ther"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/humc.2013.037","article-title":"Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa","volume":"24","author":"Conlon","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"3","key":"bib8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00439-016-1637-y","article-title":"Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial","volume":"135","author":"Ghazi","year":"2016","journal-title":"Hum Genet"},{"issue":"3","key":"bib9","first-page":"622","article-title":"Development of gene and stem cell therapy for ocular neurodegeneration","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"bib10","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1074\/jbc.M114.628297","article-title":"Cleavage of Mer tyrosine kinase (MerTK) from the cell surface contributes to the regulation of retinal phagocytosis","volume":"290","author":"Law","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/2211542004666150713191117","article-title":"Stem cells for microenvironmental modulation and retinal regeneration","volume":"5","author":"Pelaez","year":"2016","journal-title":"Curr Tissue Eng (Discontinued)"},{"issue":"2","key":"bib12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbagen.2014.10.026","article-title":"Triamcinolone regulated apopto-phagocytic gene expression patterns in the clearance of dying retinal pigment epithelial cells. A key role of Mertk in the enhanced phagocytosis","volume":"1850","author":"Albert","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"794299","DOI":"10.3389\/fmed.2021.794299","article-title":"Sustained release of Gas6 via mPEG-PLGA nanoparticles enhances the therapeutic effects of MERTK gene therapy in RCS rats","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsnano.2c05824","article-title":"Highly retina-permeating and long-acting resveratrol\/metformin nanotherapeutics for enhanced treatment of macular degeneration","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.apmt.2021.101156","article-title":"Targeting nanocomposites with anti-oxidative\/inflammatory\/angiogenic activities for synergistically alleviating macular degeneration","volume":"24","author":"Luo","year":"2021","journal-title":"Appl Mater Today"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.carbon.2022.09.045","article-title":"Anti-angiogenic carbon nanovesicles loaded with bevacizumab for the treatment of age-related macular degeneration","volume":"201","author":"Anand","year":"2023","journal-title":"Carbon"},{"issue":"10","key":"bib17","first-page":"2054","article-title":"Preservation of inner retinal responses in the aged Royal College of Surgeons rat. Evidence against glutamate excitotoxicity in photoreceptor degeneration","volume":"36","author":"Bush","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1167\/iovs.07-0291","article-title":"Photopic ERG negative response from amacrine cell signaling in RCS rat retinal degeneration","volume":"49","author":"Machida","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/81555","article-title":"Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa","volume":"26","author":"Gal","year":"2000","journal-title":"Nat Genet"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ame2.12500","article-title":"A study on the variation of cytokine and electrolyte levels in rhesus macaques, cynomolgus monkeys, and Assamese macaques","volume":"8","author":"Duan","year":"2025","journal-title":"Animal Model Exp Med"},{"issue":"2","key":"bib21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5625\/lar.2016.32.2.79","article-title":"Reference values of clinical pathology parameters in cynomolgus monkeys (Macaca fascicularis) used in preclinical studies","volume":"32","author":"Park","year":"2016","journal-title":"Lab Anim Res"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"bib23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"7","author":"Liu","year":"2022;","journal-title":"Molecules"},{"issue":"2","key":"bib24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"bib25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2008.11.033","article-title":"Modulation of the physicochemical state of interior agents to prepare controlled release liposomes","volume":"69","author":"Wang","year":"2009","journal-title":"Colloids Surf B Biointerfaces"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"132409","DOI":"10.1016\/j.cej.2021.132409","article-title":"Therapeutic hydrogel sheets programmed with multistage drug delivery for effective treatment of corneal abrasion","volume":"429","author":"Luo","year":"2022","journal-title":"Chem Eng J"},{"issue":"5","key":"bib27","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.cclet.2021.01.001","article-title":"STING-activating drug delivery systems: design strategies and biomedical applications","volume":"32","author":"Li","year":"2021","journal-title":"Chin Chem Lett"},{"issue":"1","key":"bib28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12886-021-02171-3","article-title":"Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats","volume":"22","author":"Liang","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.thromres.2024.05.002","article-title":"Immunological role of Gas6\/TAM signaling in hemostasis and thrombosis","volume":"238","author":"Li","year":"2024","journal-title":"Thromb Res"},{"issue":"1","key":"bib30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-023-02726-w","article-title":"AXL in cancer: a modulator of drug resistance and therapeutic target","volume":"42","author":"Tang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"bib31","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1097\/TP.0000000000005036","article-title":"Gas6\/AXL alleviates hepatic ischemia\/reperfusion injury by inhibiting ferroptosis via the PI3K\/AKT pathway","volume":"108","author":"Zhan","year":"2024","journal-title":"Transplantation"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.preteyeres.2018.12.002","article-title":"Immune cells in the retina and choroid: two different tissue environments that require different defenses and surveillance","volume":"70","author":"McMenamin","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"bib33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation","volume":"74","author":"Streilein","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"1","key":"bib34","doi-asserted-by":"publisher","first-page":"a041305","DOI":"10.1101\/cshperspect.a041305","article-title":"Immunology of retinitis pigmentosa and gene therapy-associated uveitis","volume":"14","author":"Yang","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"bib35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"bib36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/10837450.2017.1290106","article-title":"Development of a novel one-step production system for injectable liposomes under GMP","volume":"23","author":"Araki","year":"2018","journal-title":"Pharm Dev Technol"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"120271","DOI":"10.1016\/j.ijpharm.2021.120271","article-title":"Sterilization methods of liposomes: Drawbacks of conventional methods and perspectives","volume":"597","author":"Delma","year":"2021","journal-title":"Int J Pharm"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","article-title":"Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina","volume":"22","author":"Chandler","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"bib39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1167\/iovs.62.2.41","article-title":"Characterization of gene therapy associated uveitis following intravitreal adeno-associated virus injection in mice","volume":"62","author":"Tummala","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fimmu.2012.00296","article-title":"The privileged immunity of immune privileged organs: the case of the eye","volume":"3","author":"Benhar","year":"2012","journal-title":"Front Immunol"},{"issue":"1","key":"bib41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/jbm.a.31619","article-title":"A methodology based on the \u201canterior chamber of rabbit eyes\u201d model for noninvasively determining the biocompatibility of biomaterials in an immune privileged site","volume":"86","author":"Lu","year":"2008","journal-title":"J Biomed Mater Res A"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"103625","DOI":"10.1016\/j.scr.2024.103625","article-title":"Generation of a BEST1 Pr-EGFP reporter human embryonic stem cell line via CRISPR\/Cas9 editing","volume":"82","author":"Lu","year":"2025","journal-title":"Stem Cell Res"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2811235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:31:04Z","timestamp":1765816264000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2811235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.14.12.19","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}